Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramOfficers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.
Kurtz George0B / 239S · 10 late239 trades$59.22M
Wilhelmsen Arne Alexander0B / 47S47 trades$241.96M
TSMTAIWAN SEMICONDUCTOR MANUFACTURING CO LTDNov 5 – Nov 631 insiders$417K
DRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
MTDRMatador Resources CoNov 5 – Nov 99 insiders$642K
FERGFerguson Enterprises Inc. /DE/Oct 12 – Oct 167 insiders$7.38M
SYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
UPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M
ADUSAddus HomeCare CorpNov 6 – Nov 96 insiders$16.28M
ARQQArqit Quantum Inc.Oct 2 – Oct 136 insiders$369K| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 25 | McBee BranninChief Development Officer | CRWVCoreWeave, Inc. Open-market sale · 10b5-1 plan | SELL | $126K 1,446 sh | Jan 14, 2026 |
| 25 | Zalenko Neal F.Director |  GRFEAGLE CAPITAL GROWTH FUND, INC.Open-market purchase | BUY | $2,574 234 sh | Jan 14, 2026 traded Jan 13, 2026 |
| 25 |  Wood Anthony J.Director, CEO and Chairman BOD, 10% Owner | ROKUROKU, INC Open-market sale · 10b5-1 plan | SELL | $838K 7,799 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 25 | McBee BranninChief Development Officer | CRWVCoreWeave, Inc. Open-market sale · 10b5-1 plan | SELL | $107K 1,216 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 25 | McBee BranninChief Development Officer | CRWVCoreWeave, Inc. Open-market sale · 10b5-1 plan | SELL | $126K 1,446 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 25 | Billingsley ChesterDirector, Chief Executive Officer, 10% Owner |  MNTRMentor Capital, Inc.Open-market purchase | BUY | $106 1,200 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 25 | Ravid ChagayDirector, Chief Executive Officer |  SDOTSadot Group Inc.Open-market sale | SELL | $4,442 1,305 sh | Jan 14, 2026 traded Jan 13, 2026 |
| 24 | McBee BranninChief Development Officer | CRWVCoreWeave, Inc. Open-market sale · 10b5-1 plan | SELL | $268K 3,191 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 24 | McBee BranninChief Development Officer | CRWVCoreWeave, Inc. Open-market sale · 10b5-1 plan | SELL | $308K 3,573 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 24 | McBee BranninChief Development Officer | CRWVCoreWeave, Inc. Open-market sale · 10b5-1 plan | SELL | $518K 5,948 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 23 | DeHoff KateSee Remarks |  JOBYJoby Aviation, Inc.Open-market sale · 10b5-1 plan | SELL | $105K 7,092 sh | Jan 14, 2026 traded Jan 13, 2026 |
| 23 | Fitzgerald Kevin JosephCSO & EVP, Head of Research |  ALNYALNYLAM PHARMACEUTICALS, INC.Open-market sale · 10b5-1 plan | SELL | $73K 199 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 23 | Fitzgerald Kevin JosephCSO & EVP, Head of Research | ALNYALNYLAM PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $56K 155 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 23 | Fitzgerald Kevin JosephCSO & EVP, Head of Research | ALNYALNYLAM PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $80K 220 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 22 | McBee BranninChief Development Officer | CRWVCoreWeave, Inc. Open-market sale · 10b5-1 plan | SELL | $14K 164 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 22 | McBee BranninChief Development Officer | CRWVCoreWeave, Inc. Open-market sale · 10b5-1 plan | SELL | $33K 381 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 22 | McBee BranninChief Development Officer | CRWVCoreWeave, Inc. Open-market sale · 10b5-1 plan | SELL | $42K 482 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 22 | McBee BranninChief Development Officer | CRWVCoreWeave, Inc. Open-market sale · 10b5-1 plan | SELL | $4,740 55 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 22 | McBee BranninChief Development Officer | CRWVCoreWeave, Inc. Open-market sale · 10b5-1 plan | SELL | $4,654 54 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 22 | McBee BranninChief Development Officer | CRWVCoreWeave, Inc. Open-market sale · 10b5-1 plan | SELL | $11K 127 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 22 | McBee BranninChief Development Officer | CRWVCoreWeave, Inc. Open-market sale · 10b5-1 plan | SELL | $11K 128 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 21 | McBee BranninChief Development Officer | CRWVCoreWeave, Inc. Open-market sale · 10b5-1 plan | SELL | $65K 776 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 21 | McBee BranninChief Development Officer | CRWVCoreWeave, Inc. Open-market sale · 10b5-1 plan | SELL | $75K 868 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 21 | McBee BranninChief Development Officer | CRWVCoreWeave, Inc. Open-market sale · 10b5-1 plan | SELL | $122K 1,328 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 21 | McBee BranninChief Development Officer | CRWVCoreWeave, Inc. Open-market sale · 10b5-1 plan | SELL | $75K 869 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 21 | McBee BranninChief Development Officer | CRWVCoreWeave, Inc. Open-market sale · 10b5-1 plan | SELL | $53K 637 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 21 | Saba Capital Management, L.P.10% Owner |  GFNEW GERMANY FUND INCOpen-market sale | SELL | $24K 2,000 sh | Jan 14, 2026 traded Jan 13, 2026 |
| 21 | McBee BranninChief Development Officer | CRWVCoreWeave, Inc. Open-market sale · 10b5-1 plan | SELL | $167K 2,105 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 21 | McBee BranninChief Development Officer | CRWVCoreWeave, Inc. Open-market sale · 10b5-1 plan | SELL | $65K 775 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 21 | McBee BranninChief Development Officer | CRWVCoreWeave, Inc. Open-market sale · 10b5-1 plan | SELL | $84K 986 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 20 | Fitzgerald Kevin JosephCSO & EVP, Head of Research | ALNYALNYLAM PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $14K 39 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 20 | Fitzgerald Kevin JosephCSO & EVP, Head of Research | ALNYALNYLAM PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $5,242 14 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 20 | Fitzgerald Kevin JosephCSO & EVP, Head of Research | ALNYALNYLAM PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $26K 73 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 20 | Fitzgerald Kevin JosephCSO & EVP, Head of Research | ALNYALNYLAM PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $18K 50 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 20 | Fitzgerald Kevin JosephCSO & EVP, Head of Research | ALNYALNYLAM PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $15K 40 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 20 | Fitzgerald Kevin JosephCSO & EVP, Head of Research | ALNYALNYLAM PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $34K 92 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 20 | Fitzgerald Kevin JosephCSO & EVP, Head of Research | ALNYALNYLAM PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $31K 85 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 20 | Fitzgerald Kevin JosephCSO & EVP, Head of Research | ALNYALNYLAM PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $15K 41 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 20 | Papadopoulos DidierPresident of Aircraft OEM | JOBYJoby Aviation, Inc. Open-market sale · 10b5-1 plan | SELL | $20K 1,367 sh | Jan 14, 2026 traded Jan 13, 2026 |
| 20 | Nagendran SukumarDirector, President and Head of R&D |  TSHATaysha Gene Therapies, Inc.Open-market sale · 10b5-1 plan | SELL | $942K 200.0K sh | Jan 14, 2026 traded Jan 12, 2026 |